115 filings
Page 3 of 6
8-K
goqrfuip10 d7
14 Jun 21
Amendments to Articles of Incorporation or Bylaws
4:52pm
8-K
yvpaxqhr2sshmp2
11 Jun 21
Regulation FD Disclosure
7:10am
8-K
qq1p8 jwt1c3s15tvoqj
2 Jun 21
Other Events
9:16am
8-K
3f4u6w
27 Apr 21
CRISPR Therapeutics Provides Business Update and Reports First Quarter 2021 Financial Results
4:05pm
8-K
uwlvml8k
20 Apr 21
Entry into a Material Definitive Agreement
7:22am
8-K
mg1v1
16 Feb 21
CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2020 Financial Results
4:06pm
8-K
jeviwdhtsh1 7kj
15 Jan 21
Other Events
4:12pm
8-K
nqx5 n1twsp7r
17 Dec 20
Other Events
9:06am
8-K
q4uu1ds9gva93
11 Dec 20
Other Events
8:16am
8-K
kksuyi0y7do
7 Dec 20
Regulation FD Disclosure
7:50am
8-K
ilcz3n6jswl6v7dr25ik
4 Nov 20
Regulation FD Disclosure
9:14am
8-K
oetty
28 Oct 20
CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2020 Financial Results
8:03am
8-K
8f7jsw 25
21 Oct 20
CRISPR Therapeutics Reports Positive Top-Line Results from Its Phase 1 CARBON Trial of CTX110™ in Relapsed or Refractory CD19+ B-cell Malignancies
8:58am
8-K
ozc4k7m yfh61e
27 Jul 20
CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2020 Financial Results
4:35pm
8-K
2ac3pcqn0xmihizpw55
2 Jul 20
Crispr Therapeutics Announces Proposed Public Offering of Common Shares
4:27pm
8-K
togfeh aa
12 Jun 20
Departure of Directors or Certain Officers
4:28pm
8-K
bwjgzybqryi2d9ij
12 Jun 20
Regulation FD Disclosure
6:04am
8-K
wkv12jxhozc3is43g
14 May 20
Regulation FD Disclosure
9:11am
8-K
asi47785wri495r8l
11 May 20
Regulation FD Disclosure
9:12am
8-K
zmacmko3
28 Apr 20
CRISPR Therapeutics Provides Business Update and Reports First Quarter 2020 Financial Results
4:50pm